SCHEMBL25229491

SCHEMBL25229491

O=C(O)N1C[C@@H]2C[C@H]1CN2c1ccc([N+](=O)[O-])c(Br)c1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.37
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ CYP19A1 P11511 1/20 0.34
▸ RORC P51449 2/20 0.34
▸ GAA P10253 1/20 0.33
▸ FAAH O00519 1/20 0.32
▸ CASP6 P55212 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ MAPT P10636 3/20 0.32
▸ PKM P14618 2/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ SIRT6 Q8N6T7 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26629228 1.00 AKR1C3 (0.37) AKR1C3CHRNB2CHRNA4CYP19A1RORC
SCHEMBL30411472 0.84 HSD11B1 (0.46) MAPT
SCHEMBL30635739 0.84 HSD11B1 (0.46) MAPT
SCHEMBL25208776 0.84 AKR1C3 (0.35) AKR1C3CHRNB2CHRNA4RORCGAA
SCHEMBL25215803 0.83 CHRNB2 (0.35) AKR1C3CHRNB2CHRNA4RORCGAA
SCHEMBL26629221 0.83 CHRNB2 (0.35) AKR1C3CHRNB2CHRNA4RORCGAA
SCHEMBL22506009 0.82 MAPT (0.34) GAACASP6MAPK1MAPTPKM
SCHEMBL22652198 0.81 ALDH1A1 (0.36) CYP19A1MAPK1MAPTL3MBTL1SIRT6
SCHEMBL22652044 0.81 ALDH1A1 (0.36) CYP19A1MAPK1MAPTL3MBTL1SIRT6
SCHEMBL11904967 0.81 SIRT6 (0.42) AKR1C3RORCFAAHMAPTSIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215494-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-11-09 — — WO disclosed
WO-2023087027-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-05-19 — — WO disclosed
Send feedback